Stocks / NASDAQ / AVEO Pharmaceuticals, Inc.

AVEO Pharmaceuticals, Inc.

Our Opinion

AVEO Oncology is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.

Evidence:
http://investor.aveooncology.com/phoenix.zhtml?c=219651&p=irol-newsArticle&ID=2037554

Company Description

AVEO Oncology is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted therapeutics for oncology and other areas of unmet medical need. The company is focused on developing and commercializing its lead candidate tivozanib, a potent, selective, long half-life inhibitor of vascular endothelial growth factor 1, 2 and 3 receptors, in North America as a treatment for Renal Cell Carcinoma and other cancers.

Company website: http://www.aveooncology.com